| Name | z-arg(pmc)-oh cha |
|---|---|
| Synonyms |
Z-GININE(PMC)-OH CHA
Cbz-L-g(Pmc)-OH.CHA guanidino) Z-g(Pmc)-OH.CHA-OH CyclohexanaMine (S,E)-2-(((benzyloxy)carbonyl)amino)-5-(N'-((2,2,5,7,8-pentaMethylchroMan-6-yl)sulfonyl)forMohydrazonaMido)pentanoate 5-(3-((2,2,5,7,8-pentamethylchroman-6-yl) N-[(Benzyloxy)carbonyl]-N-{N-[(2,2,5,7,8-pentamethyl-3,4-dihydro-2H-chromen-6-yl)sulfonyl]carbamimidoyl}-L-ornithine - cyclohexanamine (1:1) Nalpha-Z-Nomega-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-ginine cyclohexylammonium salt Nα-Z-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-ginine cyclohexylammonium salt (TLC) L-Ornithine, N-[[[(3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-yl)sulfonyl]amino]iminomethyl]-N-[(phenylmethoxy)carbonyl]-, compd. with cyclohexanamine (1:1) Z-L-g(Pmc)-OH·CHA N-Cbz-N'-(2,2,5,7,8-Pentamethylchroman-6-sulfonyl)-L-arginine cyclohexylammonium salt Z-ARGININE(PMC)-OH CHA N-ALPHA-CBOBENZOXY-N-OMEGA-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL)-L-GININE CYCLOHEXYLAMMONIUM SALT Z-N-OMEGA-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL)-L-GININE CYCLOHEXYLAMMONIUM SALT Z-G(PMC)-OH CHA Cyclohexanamine (S)-2-(((benzyloxy)carbonyl)amino)-5-(3-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)guanidino)pentanoate Nα-Z-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-ginine cyclohexylammonium salt Z-G(PMC)-OH CHA //BP N-Alpha-Cbobenzoxy-N-Omega-(2,2,5,7,8- Pentamethylchroman-6-Sulfonyl)-L-ginine Cyclohexylammonium Salt Z-g(Pmc)-OH N-Cbz-N'-(2,2,5,7,8-Pentamethylchroman-6-sulfonyl)-L-ginine cyclohexylammonium salt CBZ-G(PMC)-OH CHA N-ALPHA-CBZ-NG-2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL-L-GININE CYCLOHEXYLAMMONIUM SALT Cyclohexanaminium (2S)-2-{[(Benzyloxy)carbonyl]amino}-5-{1-[(2,2,5,7,8-pentamethyl-3,4-dihydro-2H-1-benzopyran-6-yl)sulfonyl]cbamimidamido}pentanoate Cyclohexanamine (S) Cbz-L-Arg(Pmc)-OH.CHA Z-Arg(Pmc)-OH |
| Molecular Formula | C34H51N5O7S |
|---|---|
| Molecular Weight | 673.863 |
| Exact Mass | 673.350891 |
| PSA | 201.31000 |
| LogP | 8.00920 |
| Storage condition | Store at RT. |
| Hazard Codes | Xi |
|---|